|
Index of reports
> Cases resulting in life threatening events (61)
> Cases with Neutropenia (8)
Below is the selection of adverse event reports related to Paclitaxel that includes cases resulting in life threatening events where reactions include neutropenia.
Adverse event in 71 year old male receiving Paclitaxel
Reported by a physician from Belgium on 2007-07-23
Patient: 71 year old male, weighing 69.0 kg (151.8 pounds)
Adverse reactions / side effects: Pseudomonal Sepsis, Cholangitis, Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Sorafenib
Dosage: unit dose: 400 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2007-02-28
End date: 2007-03-17
Sorafenib
Dosage: unit dose: 400 mg
Administration route: Oral
Start date: 2007-03-21
End date: 2007-04-07
Sorafenib
Dosage: unit dose: 400 mg
Administration route: Oral
Start date: 2007-04-11
End date: 2007-04-28
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2007-02-27
End date: 2007-02-27
Carboplatin
Start date: 2007-04-10
End date: 2007-04-10
Carboplatin
Start date: 2007-03-20
End date: 2007-03-20
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2007-03-20
End date: 2007-03-20
Paclitaxel
Start date: 2007-02-27
End date: 2007-02-27
Paclitaxel
Start date: 2007-04-10
End date: 2007-04-10
Other drugs received by patient: Antiseptic Mouth Wash; Amoxicillin Trihydrate; Diflucan
Adverse event in female receiving Paclitaxel
Reported by a physician from United Kingdom on 2007-05-17
Patient: female
Adverse reactions / side effects: Stomatitis, Anaemia, Neutropenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Herceptin
Dosage: 288 mg, single
Indication: Breast Cancer Metastatic
Start date: 2007-03-26
Myocet
Dosage: 86 mg, single
Indication: Breast Cancer Metastatic
Start date: 2007-03-26
Paclitaxel
Dosage: 138 mg, single
Indication: Breast Cancer Metastatic
Start date: 2007-03-26
Other drugs received by patient: Mucaine; Spironolactone; Cordalin; Kytril
Adverse event in 70 year old female receiving Paclitaxel
Reported by a physician from Canada on 2007-05-07
Patient: 70 year old female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Vomiting, Nausea, Chills, Hypotension, Tachycardia, Mental Status Changes, Pyrexia, Listeria Sepsis, Hypokalaemia, Fatigue, Hypomagnesaemia, Neutropenia, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Sorafenib
Dosage: total daily dose: 400 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-14
Sorafenib
Dosage: total daily dose: 400 mg
Administration route: Oral
Start date: 2006-10-14
End date: 2006-10-21
Sorafenib
Dosage: total daily dose: 400 mg
Administration route: Oral
Start date: 2006-09-21
End date: 2006-09-27
Sorafenib
Dosage: total daily dose: 400 mg
Administration route: Oral
Start date: 2006-08-25
End date: 2006-09-11
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2006-08-24
End date: 2006-08-24
Carboplatin
Start date: 2006-09-20
End date: 2006-09-20
Carboplatin
Start date: 2006-11-13
End date: 2006-11-13
Carboplatin
Start date: 2006-10-13
End date: 2006-10-13
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2006-09-20
End date: 2006-09-20
Paclitaxel
Start date: 2006-11-13
End date: 2006-11-13
Paclitaxel
Start date: 2006-10-13
End date: 2006-10-13
Paclitaxel
Start date: 2006-08-24
End date: 2006-08-24
Other drugs received by patient: Fluconazole; Fentanyl; Fentanyl; Fentanyl; Oral Phosphoda; Omega 3 with EPA; Stresstab with Zinc and Copper; Imovane; Imovane; Imovane; Decadron; Decadron; Decadron; Decadron; Decadron; Decadron; Decadron; Decadron; Decadron; Decadron; Benadryl; Benadryl; Benadryl; Ranitidine; Ranitidine; Ranitidine; Zofran; Zofran; Zofran; Mycostatin; Eprex; Eprex; Eprex; Ferrous Fumarate; Ferrous Fumarate; Blood Transfusion; Bagbaum Cream; Senekot S; Senekot S; Dulcolax; Dulcolax; Aleve; Statex; Prochlorperazine; Maxeran; Ibuprofen; Pamidronate Disodium; Pantaloc
Adverse event in 61 year old male receiving Paclitaxel
Reported by a physician from United Kingdom on 2007-03-12
Patient: 61 year old male, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Death, Dyspnoea, Abdominal Rigidity, Pulmonary Embolism, Neutropenia, Constipation, Deep Vein Thrombosis
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Sorafenib
Dosage: total daily dose: 800 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-03
End date: 2006-11-30
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-23
End date: 2006-11-23
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-23
End date: 2006-11-23
Other drugs received by patient: Acetaminophen; Tramadol HCL; Atenolol; Omeprazole; Ondansetron; Ondansetron; Metoclopramide; Metoclopramide; Dexamethasone; Dexamethasone; Dexamethasone; Dexamethasone
Adverse event in 60 year old male receiving Paclitaxel
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-02-27
Patient: 60 year old male, weighing 74.0 kg (162.8 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, C-Reactive Protein Increased, Chills, Neutropenia, Pyrexia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Bevacizumab(bevacizumab) Pwdr + Solvent, Infusion Soln, 100mg
Dosage: 15 mg/kg, q3w, intravenous
Indication: non-Small Cell Lung Cancer
Start date: 2006-12-12
Carboplatin
Dosage: 6 auc, q3w, intravenous
Indication: non-Small Cell Lung Cancer
Start date: 2006-12-12
Paclitaxel
Dosage: 200 mg/m2, q3w, intravenous
Indication: non-Small Cell Lung Cancer
Start date: 2006-12-12
Other drugs received by patient: Diclofenac Sodium; Rebamipide (Rebamipide); Magnesium Oxide (Magnesium Oxide); Nifedipine; Valsartan; Anti-Constipation Medication NOS (Anti-Constipation Medication Nos)
Adverse event in 61 year old male receiving Paclitaxel
Reported by a physician from United Kingdom on 2007-02-26
Patient: 61 year old male, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Death, Dyspnoea, Abdominal Rigidity, Pulmonary Embolism, Neutropenia, Constipation, Deep Vein Thrombosis
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Sorafenib
Dosage: total daily dose: 800 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-03
End date: 2006-11-30
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-23
End date: 2006-11-23
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-23
End date: 2006-11-23
Other drugs received by patient: Paracetamol; Tramadol HCL; Atenolol; Omeprazole; Ondansetron; Ondansetron; Metoclopramide; Metoclopramide; Dexamethasone; Dexamethasone; Dexamethasone; Dexamethasone
Adverse event in 61 year old male receiving Paclitaxel
Reported by a physician from United Kingdom on 2007-02-20
Patient: 61 year old male, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Dyspnoea, Pulmonary Embolism, Constipation, Death, Abdominal Rigidity, Lung Adenocarcinoma, Neutropenia, Cardiac Arrest, Deep Vein Thrombosis
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Sorafenib
Dosage: total daily dose: 800 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-03
End date: 2006-11-30
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-23
End date: 2006-11-23
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-23
End date: 2006-11-23
Other drugs received by patient: Paracetamol; Tramadol HCL; Atenolol; Omeprazole; Ondansetron; Ondansetron; Metoclopramide; Metoclopramide; Dexamethasone; Dexamethasone; Dexamethasone; Dexamethasone
Adverse event in 61 year old male receiving Paclitaxel
Reported by a physician from United Kingdom on 2007-01-18
Patient: 61 year old male
Adverse reactions / side effects: Dyspnoea, Pulmonary Embolism, Constipation, Death, Abdominal Rigidity, Lung Adenocarcinoma, Neutropenia, Cardiac Arrest, Deep Vein Thrombosis
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Sorafenib
Dosage: total daily dose: 800 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-03
End date: 2006-12-01
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-23
End date: 2006-11-23
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-23
End date: 2006-11-23
Other drugs received by patient: Paracetamol; Tramadol HCL; Atenolol; Omeprazole; Ondansetron; Ondansetron; Metoclopramide; Metoclopramide; Dexamethasone; Dexamethasone; Dexamethasone; Dexamethasone
|
